In conclusion, the present findings provide the first evidence that TGF-β1/Smad3 play a role in the repression of system xc− activity and promotes lipid peroxidation to a sublethal or mild degree, rendering sub-populations of HCC cells to vulnerable to GPX4 inhibition. The gene discussed is SMAD3; the disease is hepatocellular carcinoma.